tiprankstipranks
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
Holding GB:BXP?
Track your performance easily

Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Income Statement

5 Followers

Beximco Pharmaceuticals Limited Sponsored GDR RegS Income Statement

Last quarter (Q2 2023), Beximco Pharmaceuticals Limited Sponsored GDR RegS's total revenue was $9.89B, an increase of 16.38% from the same quarter last year. In Q2, Beximco Pharmaceuticals Limited Sponsored GDR RegS's net income was $1.24B. See Beximco Pharmaceuticals Limited Sponsored GDR RegS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ 37.38B$ 39.27B$ 90.66B$ 29.49B$ 25.61B$ 22.82B
Cost of Revenue
$ 20.87B$ 21.95B$ 49.52B$ 15.57B$ 13.71B$ 12.20B
Gross Profit
$ 16.51B$ 17.31B$ 41.14B$ 13.92B$ 11.90B$ 10.62B
Operating Expense
$ 9.72B$ 10.14B$ 21.36B$ 7.26B$ 6.38B$ 5.75B
Operating Income
$ 6.79B$ 7.17B$ 19.78B$ 6.66B$ 5.51B$ 4.87B
Net Non Operating Interest Income Expense
$ -1.21B$ 1.28B$ 2.93B$ 856.31M$ 993.39M$ 993.32M
Other Income Expense
-$ -470.28M$ -3.21B---
Pretax Income
$ 6.14B$ 6.07B$ 26.07B$ 6.38B$ 4.65B$ 3.95B
Tax Provision
$ 1.61B$ 1.54B$ 4.73B$ 1.21B$ 1.11B$ 905.66M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 4.63B$ 4.61B$ 21.34B$ 5.13B$ 3.51B$ 3.03B
Basic EPS
$ 2.47$ 10.28$ 34.71$ 11.49$ 7.16$ 6.80
Diluted EPS
$ 2.47$ 10.28$ 34.71$ 11.49$ 7.16$ 6.80
Basic Average Shares
$ 446.11M$ 446.11M$ 1.34B$ 446.11M$ 490.72M$ 446.09M
Diluted Average Shares
$ 446.11M$ 446.11M$ 1.34B$ 446.11M$ 490.72M$ 446.09M
Dividend Per Share
-$ 0.03$ 10.50$ 1.52$ 1.26$ 1.15
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 30.59B$ 32.09B$ 70.88B$ -22.83B$ -20.10B$ -17.95B
Net Income From Continuing And Discontinued Operation
$ 4.63B$ 4.61B$ 21.34B$ 5.13B$ 3.51B$ 3.03B
Normalized Income
$ 4.63B$ 4.77B$ 21.28B$ 5.18B$ 3.81B$ 3.20B
Interest Expense
$ 1.14B-----
EBIT
$ 7.27B$ 7.31B$ 23.14B$ 7.18B$ 5.64B$ 4.93B
EBITDA
$ 7.40B$ 9.37B$ 27.12B$ 7.18B$ 5.64B$ 4.93B
Currency in USD

Beximco Pharmaceuticals Limited Sponsored GDR RegS Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis